FDA NDC Directory · JSON-LD · Markdown
NDC 10135-820 · HUMAN PRESCRIPTION DRUG · SOLUTION
| Labeler / Manufacturer | Marlex Pharmaceuticals Inc |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA212183 |
| Dosage form / route | SOLUTION · ORAL |
| Active ingredients | POTASSIUM CHLORIDE (3 g/4.75g) |
| Marketing started | 20250801 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).